步長製藥(603858.SH):陝西省現代創新中藥研究院取得了營業執照
格隆匯 11 月 23日丨步長製藥(603858.SH)公佈,公司於2020年8月27日召開了第三屆董事會第三十四次(臨時)會議,審議通過了《關於公司全資子公司與關聯方共同投資設立控股子公司暨關聯交易的議案》,公司全資子公司陝西步長醫藥研究院有限公司及陝西步長製藥有限公司擬與他方共同對外投資設立一家控股子公司。
近日,陝西省現代創新中藥研究院有限公司取得了咸陽市行政審批服務局核發的營業執照,經營範圍:一般項目:醫學研究和試驗發展;技術服務、技術開發、技術諮詢、技術交流、技術轉讓、技術推廣;企業管理諮詢;軟件開發;軟件銷售;大數據服務;銷售代理;智能控制系統集成(上述項目僅限藥學領域);中草藥種植;中草藥收購;製藥專用設備製造;製藥專用設備銷售;工程管理服務;專業設計服務;專用設備修理;工業自動控制系統裝置銷售;運行效能評估服務;日用化學產品製造;日用化學產品銷售;藥物檢測儀器製造;藥物檢測儀器銷售;環境保護專用設備製造;環境保護專用設備銷售;資源再生利用技術研發(除依法須經批准的項目外,憑營業執照依法自主開展經營活動)。許可項目:藥品生產;藥品批發;保健食品生產;檢驗檢測服務;特殊醫學用途配方食品生產;特殊醫學用途配方食品銷售;建設工程監理;工程造價諮詢業務;建築智能化系統設計;建築智能化工程施工(依法須經批准的項目,經相關部門批准後方可開展經營活動,具體經營項目以審批結果為準)
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.